Combination drug therapy for hypertension

  • 176 Pages
  • 4.73 MB
  • English

Author"s Pub. House, Lippincott-Raven Publishers , New York, Philadelphia
Antihypertensive Agents -- therapeutic use, Antihypertensive agents, Drug Therapy, Combination, Hypertension -- chemotherapy, Hypertension -- drug th
Statementedited by Lionel H. Opie, Franz H. Messerli.
ContributionsMesserli, Franz H., Opie, Lionel H.
LC ClassificationsRC685 .H8C65 1997
The Physical Object
Paginationxiv, 176 p. :
ID Numbers
Open LibraryOL20206532M
ISBN 101881063054

Nearly half of patients with "stage-2 hypertension" (BP ≥/90 mm Hg) are low-risk (% and % with year risks. ISBN: OCLC Number: Description: xiv, pages: illustrations: Contents: Ch. Principles of Combination Therapy for Hypertension / Lionel H.

Details Combination drug therapy for hypertension EPUB

Opie --Ch. tory Blood Pressure Monitoring for Antihypertensive Drug Studies and Combination Therapy / Giuseppe Mancia --Ch. -Dose Combinations with [beta]-Adrenergic Blockers and Diuretics. Combination therapy is treatment with two or more agents administered separately or in a fixed-dose combination pill and is required by most patients with hypertension to reach target blood Cited by: Combination Therapy and Hypertension: Pocketbook (Martin Dunitz Medical Pocket Books) 1st Edition by Michael Schachter (Author) ISBN ISBN Why is ISBN important.

ISBN. This bar-code number lets you verify that you're getting exactly the right version or edition of a book Author: Michael Schachter. Judith A. Whitworth, in Comprehensive Hypertension, Drug Combination Therapy.

Combination therapy of several of the available drug classes has been shown to produce blood pressure reductions that are greater than those produced by any group of individual agents used alone.

The Hypertension Optimal Treatment (HOT) study in which blood pressure was lowered to below 90 mmHg in over 90%. Combination Therapy. Combination therapy is defined as disease treatment with two or more drugs to achieve efficacy with lower doses or lower toxicity drugs, chemosensitize cells so that an additional compound can be more potent, gain additive or synergistic effects, or combat expected acquired resistance or minimize the possibility for development of drug resistance.

This page includes the following topics and synonyms: Resistant Hypertension, Hypertension Combination Therapy, Combination Antihypertensive Therapy, Refractory Hypertension, Refractory Hypertensive Populations. Combination drug therapy for hypertension book Citation | Combination Drug Therapy in the Elderly | Awareness, treatment, and control of hypertension in the United States have been improving for geriatric patients (1).

However. Transitions clearly have a role in enhancing the convenience and safety of pulmonary hypertension therapy for some patients. Combination therapy looks promising and may well represent the future. Get this from a library. Combination therapy in hypertension.

[Joel M Neutel] -- For over 30 years, the stepped care approach has been used in the management and treatment of hypertension. This approach advocates the use of initial monotherapy to reach the desired blood pressure.

Later chapters are devoted to the effects of combination drug therapy on such crucial issues as cardiac and renal alterations, stroke, and cardiovascular risk factors.

In total this book, which is well presented and easy to read, constitutes a first deserving attempt to promote combination drug therapy in Author: Alain Simon.

Adding to this, Combination Therapy in Hypertension will cover current control rates of blood pressure worldwide, the benefits of monotherapy and combination therapy, examine the effectiveness, risk of adverse effects, compliance, and cost of the available therapies and will also include information on relevant outcome studies.

A prominent advocate of the need for combination therapy in the management of hypertension, Dr. Neutel has researched and lectured extensively on the subject and has authored numerous abstracts, journal articles and book chapters.

He has also been a reviewer and served on the editorial boards for a number of high profile journals. PSAP BOOK 1 t Cardiology 8 Hypertension readings of –/80–89 mm Hg should receive drug ther-apy (Muntner ). Hypertension prevalence increases as patients age.

Using the lower threshold as defined by the ACC/AHA guide-lines, the prevalence of hypertension for patients 20–44 years of age is 30% in men and 19% in women. We encouraged combination drug therapy, especially in adults with stage 2 hypertension and in black adults with hypertension.

We recommended combination drug therapy, including fixed-dose combinations, with agents that are deemed to provide complementary effects.

For example, diuretics may stimulate the renin-angiotensin-aldosterone system. Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure).

Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial ce suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of.

Antihypertensive Agents () Definition (MEDLINEPLUS) High blood pressure, also called hypertension, usually has no it can cause serious problems such as stroke, heart failure, heart attack and kidney you cannot control your high blood pressure through lifestyle changes such as losing weight and reducing sodium in your diet, you may need medicines.

Chrysant SG, Izzo JL Jr, Kereiakes DJ, Littlejohn T 3rd, Oparil S, Melino M, et al. Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study.

Furthermore, in hypertension, single pill combinations include lower doses of each drug than would be necessary to achieve goals with monotherapy, which may explain their better tolerability compared with higher dose monotherapy. Combination therapy is Author: Ferdinando Iellamo, Karl Werdan, Krzysztof Narkiewicz, Giuseppe Rosano, Maurizio Volterrani.

Patients with hypertension (systolic blood pressure ≥ mmHg or diastolic blood pressure ≥90 mmHg) should receive drug therapy in addition to lifestyle/behavioral therapy. Initial drug therapy may be with any drug class currently indicated for the treatment of hypertension.

However, some drug classes (ACE inhibitors, β-blockers, and. To compare the clinical efficacy and cost of therapy with an amiloride-hydrochlorothiazide combination versus hydrochlorothiazide and a wax-matrix potassium supplement, we reviewed the medical records of 20 hypertensive men who had received both treatments.

based on the lowest listed price in the Drug Topics Red Book and also in the Red Cited by: 1. Purchase Comprehensive Hypertension - 1st Edition. Print Book & E-Book. ISBN  Almost half of all marketed drugs are fixed combination preparations, yet the World Health Organization included only 7 in its list of ‘essential’ drugs.

There has been little scientific study of these preparations but much emotion and rhetoric has been expended both for and against them. Potential advantages of fixed combination preparations include: increased compliance, synergy and Cited by:   The current JNC7 guidelines recommend administering more than one drug as initial therapy for patients with BP >20 mmHg systolic or >10 mmHg diastolic above goal, with one of the drugs in the combination being a thiazide-type diuretic.1 Treatment of hypertension with angiotensin receptor blockers (ARBs) alone or in combination is considered a Cited by:   In this review, we discuss several AI methods that have been successfully implemented in several instances of combination drug therapy from HIV, hypertension, infectious diseases to cancer.

The data clearly show that the combination of rule-based expert systems with machine learning algorithms may be promising direction in this by: Hypertension Canada guidelines. Hypertension Canada website. Accessed November 7, Misra S, Stevermer JJ. ACE inhibitors and ARBs: one or the other—not both—for high-risk patients.

J Fam Pract.

Description Combination drug therapy for hypertension FB2

;58(1)   Chapter Author - Michael A. Weber Combination drug therapy is being considered as an initial approach to antihypertensive treatment. Weber provides the arguments for the use of combination therapy regarding issues of treatment adherence, cost, efficacy, and side effects.

The above is a synopsis. To read more, please purchase the book from Cardiotext Publishing.

Download Combination drug therapy for hypertension EPUB

A combination drug or a fixed-dose combination (FDC) is a medicine that includes two or more active ingredients combined in a single dosage form. Terms like "combination drug" or "combination drug product" can be common shorthand for a FDC product (since most combination drug products are currently FDCs), although the latter is more precise if in fact referring to a mass-produced product.

Combination Therapy in Hypertension by Joel Neutel,available at Book Depository with free delivery : Joel Neutel. Bridging for Drug-Device and Biologic-Device Combination Products - 12/ Compliance Policy for Combination Product Postmarketing Safety Reporting - 04/.

7th International Conference on Fixed Combination Therapy in Cardiovascular Disease, Hypertension, Diabetes, Dyslipidemia and the Cardio-Metabolic Syndrome It is our pleasure to invite you to the 7th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus.This best-selling clinical reference by a world-renowned authority on hypertension was listed as the #1 reference book for hypertension by the American Society for Hypertension in Dr.

Kaplan integrates the latest basic science findings and clinical trial data and presents up-to-date, practical, evidence-based recommendations for treatment.This chapter will be most useful after having a basic understanding of the material in the section on hypertension in Chapter 27 Drug Therapy of Myocardial Ischemia and Hypertension in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 12th Edition (pp ), as well as material in Chapter 25 Regulation of Renal Volume and Vascular Volume and Chapter 26 Renin and Angiotensin.